Abbott Vascular’s Ferolyn Powell talks about the company’s MitraClip technology, which is used to treat a common heart valve condition called mitral regurgitation.
The MitraClip device is designed to reduce significant mitral regurgitation by clipping together the leaflets of the mitral valve, one of the four valves of the heart.
Powell, vice president and general manager of Abbott’s structural heart division, was interviewed at the Cleveland Clinic Medical Innovation Summit, which focused on cardiovascular disease.
presented by
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
